Creekmur Asset Management LLC Has $911,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Creekmur Asset Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 288.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,854 shares of the medical equipment provider’s stock after purchasing an additional 1,377 shares during the quarter. Creekmur Asset Management LLC’s holdings in Intuitive Surgical were worth $911,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Mirador Capital Partners LP lifted its holdings in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after purchasing an additional 50 shares during the last quarter. Advisors Asset Management Inc. raised its holdings in Intuitive Surgical by 18.1% in the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after acquiring an additional 1,129 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares in the last quarter. Brookstone Capital Management raised its holdings in Intuitive Surgical by 22.4% in the 2nd quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after acquiring an additional 2,289 shares in the last quarter. Finally, M&G Plc raised its holdings in Intuitive Surgical by 53.5% in the 2nd quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock valued at $2,256,000 after acquiring an additional 1,766 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of the company’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,558,968.56. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of the company’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,558,968.56. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 53,038 shares of company stock worth $25,857,344. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Up 0.2 %

NASDAQ ISRG opened at $517.19 on Wednesday. The business’s 50-day moving average price is $489.22 and its two-hundred day moving average price is $444.82. Intuitive Surgical, Inc. has a 12 month low of $260.17 and a 12 month high of $523.34. The firm has a market capitalization of $184.21 billion, a PE ratio of 83.01, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Royal Bank of Canada boosted their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.